1. Seife, M. Evolution of the principal US food & drug laws. In: Sharma KN, Sharma KK, Sen P, editors. Generic drugs, bioequivalence and pharmacokinetics: Proceedings of the Indo-US Symposium, New Delhi, University College of Medical Sciences, 1990. Ring Road, New Delhi 110-029: University College of Medical Sciences; 1990. p. 7–14.
2. U.S. Department of Health and Human Services. A brief history of the center for drug evaluation and research. 2009.
http://www.fda.gov/cder/about/history/Histext.htm
. Accessed March 2009.
3. U.S. Department of Health and Human Services. A brief history of the center for drug evaluation and research. 2009.
http://www.fda.gov/aboutFDA/whatwedo/history/thisweek/ucm117833.htm
.
4. Skelly JP. Bioavailability policies and guidelines; in industrial bioavailability and pharmacokinetics—guidelines and controls. In: Martin A, Doluisio JT, editors. College of pharmacy, drug dynamics institute. Austin: University of Texas; 1977. p. 2–41.
5. United States of America versus Pharmadyne Laboratories and Bernard Bedrick; United States District Court, District of New Jersey. 1980.